Arsenic Trioxide vs Atezolizumab

## Arsenic Trioxide vs Atezolizumab: Overview

This comparison examines the pharmacological differences between **Arsenic Trioxide** and **Atezolizumab**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

## Pharmacokinetics

**Half-life**: Arsenic Trioxide — N/A; Atezolizumab — 27 days.

## Chemical Properties

**Type**: Arsenic Trioxide — Small molecule; Atezolizumab — Antibody.